Challenges in the Manufacture of Antibody Drug Conjugates
Antibody drug conjugates (ADCs) represent potent new weapons
in the anticancer drug arsenal – but their manufacture presents a series
of engineering and chemistry challenges.
By Thomas Roher at Lonza Custom Manufacturing, Chemical Manufacturing (March 2010)
Keywords: manufacture, Lonza, ADC, Antibody, weapon, drug, cancer, molecule, chemotherapeutic, silver bullet, challenge, Rohrer